Tag: Astellas

Phase 3 EMBARK Study Confirms XTANDI Plus Leuprolide Improves Overall Survival in Non-Metastatic Prostate Cancer

Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the…

ME Desk